| UniProt ID | EF1D_HUMAN | |
|---|---|---|
| UniProt AC | P29692 | |
| Protein Name | Elongation factor 1-delta | |
| Gene Name | EEF1D | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 281 | |
| Subcellular Localization | Isoform 2: Nucleus . | |
| Protein Description | Isoform 1: EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP, regenerating EF-1-alpha for another round of transfer of aminoacyl-tRNAs to the ribosome.; Isoform 2: Regulates induction of heat-shock-responsive genes through association with heat shock transcription factors and direct DNA-binding at heat shock promoter elements (HSE).. | |
| Protein Sequence | MATNFLAHEKIWFDKFKYDDAERRFYEQMNGPVAGASRQENGASVILRDIARARENIQKSLAGSSGPGASSGTSGDHGELVVRIASLEVENQSLRGVVQELQQAISKLEARLNVLEKSSPGHRATAPQTQHVSPMRQVEPPAKKPATPAEDDEDDDIDLFGSDNEEEDKEAAQLREERLRQYAEKKAKKPALVAKSSILLDVKPWDDETDMAQLEACVRSIQLDGLVWGASKLVPVGYGIRKLQIQCVVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNKI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATNFLAHE ------CCCCCCCCC | 15.96 | 22223895 | |
| 10 | 2-Hydroxyisobutyrylation | TNFLAHEKIWFDKFK CCCCCCCCHHHHCCC | 35.06 | - | |
| 10 | Acetylation | TNFLAHEKIWFDKFK CCCCCCCCHHHHCCC | 35.06 | 26822725 | |
| 10 | Ubiquitination | TNFLAHEKIWFDKFK CCCCCCCCHHHHCCC | 35.06 | 21890473 | |
| 10 (in isoform 1) | Ubiquitination | - | 35.06 | 21890473 | |
| 10 | Ubiquitination | TNFLAHEKIWFDKFK CCCCCCCCHHHHCCC | 35.06 | 21890473 | |
| 12 (in isoform 2) | Phosphorylation | - | 13.37 | - | |
| 15 | 2-Hydroxyisobutyrylation | HEKIWFDKFKYDDAE CCCHHHHCCCCCHHH | 33.99 | - | |
| 15 | Acetylation | HEKIWFDKFKYDDAE CCCHHHHCCCCCHHH | 33.99 | 26051181 | |
| 15 | Ubiquitination | HEKIWFDKFKYDDAE CCCHHHHCCCCCHHH | 33.99 | 21890473 | |
| 15 (in isoform 1) | Ubiquitination | - | 33.99 | 21890473 | |
| 15 | Ubiquitination | HEKIWFDKFKYDDAE CCCHHHHCCCCCHHH | 33.99 | 21890473 | |
| 17 | Acetylation | KIWFDKFKYDDAERR CHHHHCCCCCHHHHH | 54.21 | 19608861 | |
| 17 | Ubiquitination | KIWFDKFKYDDAERR CHHHHCCCCCHHHHH | 54.21 | 19608861 | |
| 18 | Phosphorylation | IWFDKFKYDDAERRF HHHHCCCCCHHHHHH | 23.37 | 21945579 | |
| 22 | Ubiquitination | KFKYDDAERRFYEQM CCCCCHHHHHHHHHH | 51.92 | 21890473 | |
| 24 | Methylation | KYDDAERRFYEQMNG CCCHHHHHHHHHHCC | 29.97 | - | |
| 26 | Nitration | DDAERRFYEQMNGPV CHHHHHHHHHHCCCC | 11.93 | - | |
| 26 | Phosphorylation | DDAERRFYEQMNGPV CHHHHHHHHHHCCCC | 11.93 | 21945579 | |
| 27 | Ubiquitination | DAERRFYEQMNGPVA HHHHHHHHHHCCCCC | 40.41 | 21890473 | |
| 29 | Sulfoxidation | ERRFYEQMNGPVAGA HHHHHHHHCCCCCCC | 4.12 | 28465586 | |
| 37 | Phosphorylation | NGPVAGASRQENGAS CCCCCCCCCCCCCCC | 33.31 | 21945579 | |
| 37 (in isoform 3) | Phosphorylation | - | 33.31 | 22496350 | |
| 40 (in isoform 3) | Phosphorylation | - | 57.43 | 25159151 | |
| 41 (in isoform 3) | Phosphorylation | - | 42.89 | 28355574 | |
| 44 | Phosphorylation | SRQENGASVILRDIA CCCCCCCCHHHHHHH | 15.87 | 23401153 | |
| 46 (in isoform 3) | Phosphorylation | - | 2.12 | 30108239 | |
| 47 (in isoform 3) | Phosphorylation | - | 3.64 | 20068231 | |
| 49 (in isoform 3) | Phosphorylation | - | 35.14 | 26552605 | |
| 50 (in isoform 3) | Phosphorylation | - | 1.95 | 27251275 | |
| 59 | Acetylation | RARENIQKSLAGSSG HHHHHHHHHHCCCCC | 43.57 | 26051181 | |
| 59 | Ubiquitination | RARENIQKSLAGSSG HHHHHHHHHHCCCCC | 43.57 | 21890473 | |
| 59 (in isoform 1) | Ubiquitination | - | 43.57 | 21890473 | |
| 60 | Phosphorylation | ARENIQKSLAGSSGP HHHHHHHHHCCCCCC | 13.69 | 29255136 | |
| 64 | Phosphorylation | IQKSLAGSSGPGASS HHHHHCCCCCCCCCC | 26.89 | 23401153 | |
| 64 (in isoform 4) | Phosphorylation | - | 26.89 | 25159151 | |
| 65 | Phosphorylation | QKSLAGSSGPGASSG HHHHCCCCCCCCCCC | 48.35 | 30278072 | |
| 70 | Phosphorylation | GSSGPGASSGTSGDH CCCCCCCCCCCCCCC | 34.90 | 23911959 | |
| 71 | Phosphorylation | SSGPGASSGTSGDHG CCCCCCCCCCCCCCC | 45.62 | 30278072 | |
| 71 (in isoform 4) | Phosphorylation | - | 45.62 | 25627689 | |
| 73 | Phosphorylation | GPGASSGTSGDHGEL CCCCCCCCCCCCCCE | 31.33 | 21712546 | |
| 74 | Phosphorylation | PGASSGTSGDHGELV CCCCCCCCCCCCCEE | 45.83 | 23898821 | |
| 77 (in isoform 2) | Phosphorylation | - | 34.84 | 24300666 | |
| 83 | Acetylation | DHGELVVRIASLEVE CCCCEEEEEEEEEEC | 15.98 | 19608861 | |
| 83 | Ubiquitination | DHGELVVRIASLEVE CCCCEEEEEEEEEEC | 15.98 | 19608861 | |
| 83 | Ubiquitination | DHGELVVRIASLEVE CCCCEEEEEEEEEEC | 15.98 | 21890473 | |
| 86 | Phosphorylation | ELVVRIASLEVENQS CEEEEEEEEEECCCH | 23.77 | 30266825 | |
| 88 | Acetylation | VVRIASLEVENQSLR EEEEEEEEECCCHHH | 45.34 | 19608861 | |
| 88 | Ubiquitination | VVRIASLEVENQSLR EEEEEEEEECCCHHH | 45.34 | 19608861 | |
| 91 (in isoform 2) | Phosphorylation | - | 41.75 | 18669648 | |
| 93 | Acetylation | SLEVENQSLRGVVQE EEEECCCHHHHHHHH | 31.45 | 19608861 | |
| 93 | Phosphorylation | SLEVENQSLRGVVQE EEEECCCHHHHHHHH | 31.45 | 20068231 | |
| 93 | Ubiquitination | SLEVENQSLRGVVQE EEEECCCHHHHHHHH | 31.45 | 19608861 | |
| 94 (in isoform 2) | Phosphorylation | - | 3.88 | 25159151 | |
| 95 | Methylation | EVENQSLRGVVQELQ EECCCHHHHHHHHHH | 40.90 | - | |
| 98 | Acetylation | NQSLRGVVQELQQAI CCHHHHHHHHHHHHH | 3.99 | 19608861 | |
| 98 | Ubiquitination | NQSLRGVVQELQQAI CCHHHHHHHHHHHHH | 3.99 | 19608861 | |
| 106 | Phosphorylation | QELQQAISKLEARLN HHHHHHHHHHHHHHH | 33.92 | 22617229 | |
| 107 | Acetylation | ELQQAISKLEARLNV HHHHHHHHHHHHHHH | 44.21 | 19608861 | |
| 107 | Ubiquitination | ELQQAISKLEARLNV HHHHHHHHHHHHHHH | 44.21 | 21890473 | |
| 107 (in isoform 1) | Ubiquitination | - | 44.21 | 21890473 | |
| 107 (in isoform 2) | Phosphorylation | - | 44.21 | 25693802 | |
| 117 | 2-Hydroxyisobutyrylation | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | - | |
| 117 | Acetylation | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | 19608861 | |
| 117 | Malonylation | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | 26320211 | |
| 117 | Succinylation | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | - | |
| 117 | Succinylation | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | - | |
| 117 | Ubiquitination | ARLNVLEKSSPGHRA HHHHHHHHCCCCCCC | 52.66 | 19608861 | |
| 118 | Phosphorylation | RLNVLEKSSPGHRAT HHHHHHHCCCCCCCC | 32.18 | 25159151 | |
| 119 | Phosphorylation | LNVLEKSSPGHRATA HHHHHHCCCCCCCCC | 46.07 | 25159151 | |
| 125 | Phosphorylation | SSPGHRATAPQTQHV CCCCCCCCCCCCCCC | 38.54 | 29255136 | |
| 129 | Phosphorylation | HRATAPQTQHVSPMR CCCCCCCCCCCCCCC | 21.42 | 29255136 | |
| 133 | Phosphorylation | APQTQHVSPMRQVEP CCCCCCCCCCCCCCC | 15.74 | 20201521 | |
| 135 | Sulfoxidation | QTQHVSPMRQVEPPA CCCCCCCCCCCCCCC | 3.49 | 21406390 | |
| 147 | Phosphorylation | PPAKKPATPAEDDED CCCCCCCCCCCCCCC | 31.40 | 19664994 | |
| 162 | Phosphorylation | DDIDLFGSDNEEEDK CCCCCCCCCCHHHHH | 29.90 | 19664994 | |
| 169 | Ubiquitination | SDNEEEDKEAAQLRE CCCHHHHHHHHHHHH | 53.16 | - | |
| 178 | Methylation | AAQLREERLRQYAEK HHHHHHHHHHHHHHH | 30.34 | - | |
| 182 | Phosphorylation | REERLRQYAEKKAKK HHHHHHHHHHHHCCC | 15.42 | 29341593 | |
| 185 | Acetylation | RLRQYAEKKAKKPAL HHHHHHHHHCCCCCE | 50.27 | 26051181 | |
| 185 | Succinylation | RLRQYAEKKAKKPAL HHHHHHHHHCCCCCE | 50.27 | 23954790 | |
| 185 | Ubiquitination | RLRQYAEKKAKKPAL HHHHHHHHHCCCCCE | 50.27 | - | |
| 186 | Ubiquitination | LRQYAEKKAKKPALV HHHHHHHHCCCCCEE | 57.87 | - | |
| 188 | Ubiquitination | QYAEKKAKKPALVAK HHHHHHCCCCCEEEC | 69.07 | - | |
| 189 | 2-Hydroxyisobutyrylation | YAEKKAKKPALVAKS HHHHHCCCCCEEECC | 40.14 | - | |
| 189 | Ubiquitination | YAEKKAKKPALVAKS HHHHHCCCCCEEECC | 40.14 | 21906983 | |
| 196 | Phosphorylation | KPALVAKSSILLDVK CCCEEECCEEEECCC | 16.93 | 25627689 | |
| 197 | Phosphorylation | PALVAKSSILLDVKP CCEEECCEEEECCCC | 19.29 | 22985185 | |
| 203 | Acetylation | SSILLDVKPWDDETD CEEEECCCCCCCCCC | 39.80 | 19825591 | |
| 203 | Sumoylation | SSILLDVKPWDDETD CEEEECCCCCCCCCC | 39.80 | - | |
| 208 | Ubiquitination | DVKPWDDETDMAQLE CCCCCCCCCCHHHHH | 44.21 | 21890473 | |
| 209 | Phosphorylation | VKPWDDETDMAQLEA CCCCCCCCCHHHHHH | 37.76 | 22817901 | |
| 211 | Sulfoxidation | PWDDETDMAQLEACV CCCCCCCHHHHHHHH | 3.14 | 30846556 | |
| 220 | Phosphorylation | QLEACVRSIQLDGLV HHHHHHHHHCCCCEE | 8.35 | 21712546 | |
| 225 | Ubiquitination | VRSIQLDGLVWGASK HHHHCCCCEEECCCC | 30.62 | 21890473 | |
| 231 | Phosphorylation | DGLVWGASKLVPVGY CCEEECCCCCEEECC | 23.68 | 21712546 | |
| 232 | Ubiquitination | GLVWGASKLVPVGYG CEEECCCCCEEECCC | 53.63 | 2189047 | |
| 232 (in isoform 1) | Ubiquitination | - | 53.63 | 21890473 | |
| 238 | Phosphorylation | SKLVPVGYGIRKLQI CCCEEECCCEEEEEE | 15.04 | 25394399 | |
| 242 | 2-Hydroxyisobutyrylation | PVGYGIRKLQIQCVV EECCCEEEEEEEEEE | 42.71 | - | |
| 242 | Ubiquitination | PVGYGIRKLQIQCVV EECCCEEEEEEEEEE | 42.71 | - | |
| 247 (in isoform 2) | Phosphorylation | - | 3.85 | 25884760 | |
| 265 | Ubiquitination | LLEEEITKFEEHVQS HHHHHHHHHHHHHHH | 57.34 | - | |
| 280 | 2-Hydroxyisobutyrylation | VDIAAFNKI------ CCHHHHCCC------ | 43.25 | - | |
| 280 | Ubiquitination | VDIAAFNKI------ CCHHHHCCC------ | 43.25 | - | |
| 376 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 381 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 403 | Phosphorylation | --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 410 | Phosphorylation | ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- | 24719451 | ||
| 425 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 426 | Phosphorylation | -------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 430 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------ | 24719451 | ||
| 431 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 436 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------ | 27251275 | ||
| 437 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 24719451 | ||
| 452 | Phosphorylation | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 24719451 | ||
| 473 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 483 (in isoform 2) | Ubiquitination | - | - | ||
| 484 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | 27251275 | ||
| 485 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 24719451 | ||
| 491 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 495 | Phosphorylation | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 499 | Phosphorylation | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 513 | Phosphorylation | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 27251275 | ||
| 528 | Phosphorylation | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 24719451 | ||
| 598 (in isoform 2) | Ubiquitination | - | 21890473 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EF1D_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EF1D_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, AND MASSSPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17; LYS-107 AND LYS-117, ANDMASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Unbiased functional proteomics strategy for protein kinase inhibitorvalidation and identification of bona fide protein kinase substrates:application to identification of as a substrate for CK2."; Gyenis L., Duncan J.S., Turowec J.P., Bretner M., Litchfield D.W.; J. Proteome Res. 10:4887-4901(2011). Cited for: PHOSPHORYLATION AT SER-162 BY CK2. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129; SER-133 ANDSER-162, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, AND MASSSPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY. | |
| "Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-119; THR-129;SER-133; THR-147 AND SER-162, AND MASS SPECTROMETRY. | |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, ANDMASS SPECTROMETRY. | |
| "Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY. | |
| "Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. | |